Trailing-twelve-month (TTM) revenue is $2.10 Billion with a year-over-year growth of +17.94%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $493,849,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q3 FY2026Period ended 2025-12-31 | $515,473,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-09 |
| Q4 FY2026Period ended 2026-03-31 | $531,716,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-20 |
| Q1 FY2027Period ended 2026-06-30 | $554,548,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $2,095,586,000 |
Current P/S: $14,748,672,090 market capitalization ÷ $2,095,586,000 TTM revenue = 7.04x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $554.55M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| License | $1M | $54,000 | N/A | N/A | N/A | N/A |
| Service | $47M | $59M | $75M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $78M | $96M | $111M | $131M | $151M | $193M |
| EMEA | $217M | $279M | $292M | $355M |
$2.10B
$2.10 Billion
+17.94%
vs. $1.78B a year ago (TTM)
+22.57%
5 Year compound annual growth rate
1 Year
+17.94%
3 Year
+19.62%
5 Year
+22.57%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $2.02B | +$319.70M | +18.82% |
| 2025 | $1.70B | +$268.15M | +18.75% |
| 2024 | $1.43B | +$272.00M | +23.48% |
| 2023 | $1.16B | +$229.09M | +24.65% |
| 2022 | $929.45M | +$225.94M | +32.12% |
| 2021 |
TTM Growth
+17.94%
3-Year CAGR
+19.62%
5-Year CAGR
+22.57%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 33 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $71M |
| $77M |
| $89M |
| Subscription and Circulation | $655M | $870M | $1.1B | $1.4B | $1.6B | $1.9B |
|---|
| $649M |
| Latin America | $20M | $41M | $64M | $93M | $103M | $159M |
|---|
| North America | $388M | $513M | $691M | $852M | $1.0B | $1.0B |
|---|
| $703.51M |
| +$157.71M |
| +28.89% |
| 2020 | $545.80M | +$114.84M | +26.65% |
| 2019 | $430.97M | +$32.92M | +8.27% |
| 2018 | $398.05M | ($8.33M) | (2.05%) |
